Trial Profile
A Multi-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion (SUN-131-03)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Aug 2021
Price :
$35
*
At a glance
- Drugs SUN 131 (Primary)
- Indications Chalazion
- Focus Registrational; Therapeutic Use
- Acronyms SUNRISE
- Sponsors Senju Pharmaceutical
- 17 Aug 2018 Status changed from recruiting to completed.
- 17 Aug 2017 New trial record